Evidence map›Paper›PMID 31981212›Full record

ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2020

A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel.

Sanjay Kalra, Sarita Bajaj, Surendra Kumar Sharma, Gagan Priya, Manash P Baruah, Debmalya Sanyal, Sambit Das, Tirthankar Chaudhury, Kalyan Kumar Gangopadhyay, Ashok Kumar Das and 23 more

Open access · goldAbstract readReview
In one paragraph

Review in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Counseling for Insulin Icodec: A Proposed Practitioner's Guide.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  6. TheAnnals of medicine · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 8 countries.

Sanjay KalraDepartment of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana, India. brideknl@gmail.com.
Sarita BajajDepartment of Endocrinology, MLN Medical College, Allahabad, Uttar Pradesh, India.
Surendra Kumar SharmaDiabetes, Thyroid and Endocrine Centre, Galaxy Specialty Centre, Jaipur, Rajasthan, India.
Gagan PriyaDepartment of Endocrinology, Fortis Hospital, Chandigarh, Punjab, India.
Manash P BaruahDepartment of Endocrinology, Excel Hospital, Guwahati, Assam, India.
Debmalya SanyalDepartment of Endocrinology, KPC Medical College, Kolkata, West Bengal, India.
Sambit DasDepartment of Endocrinology, Apollo Hospitals, Bhubaneswar, India.
Tirthankar ChaudhuryDepartment of Diabetes and Endocrinology, Apollo Gleneagles Hospital, Kolkata, India.
Kalyan Kumar GangopadhyayDepartment of Diabetology and Endocrinology, Peerless Hospital and B K Roy Research Centre, Kolkata, West Bengal, India.
Ashok Kumar DasDepartment of Endocrinology and Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India.
Bipin SethiDepartment of Endocrinology, CARE Hospitals, Hyderabad, Telangana, India.
Vageesh AyyarDepartment of Endocrinology, St John Hospital, Bangalore, Karnataka, India.
Shehla ShaikhDepartment of Endocrinology, KGN Institute of Diabetes and Endocrinology, Mumbai, Maharashtra, India.
Parag ShahDepartment of Endocrinology and Diabetes, Gujarat Endocrine Centre, Ahmedabad, India.
Sushil JindalDepartment of Endocrinology, Peoples Medical College and Hospital, Bhopal, Madhya Pradesh, India.
Vaishali DeshmukhDepartment of Endocrinology, Deshmukh Clinic and Research Centre, Pune, Maharashtra, India.
Joel DaveDepartment of Endocrinology, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Aslam AmodDepartment of Endocrinology, Life Chatsmed Garden Hospital, Durban, South Africa.
Ansumali JoshiDepartment of Endocrinology, Kathmandu Diabetes and Thyroid Centre, Kathmandu, Nepal.
Sunil PokharelDepartment of Endocrinology, Alka Hospital, Kathmandu, Nepal.
Faruque PathanDepartment of Endocrinology, Bangladesh Institute of Research and Rehabilitation for Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.
Faria AfsanaDepartment of Endocrinology, Bangladesh Institute of Research and Rehabilitation for Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.
Indrajit PrasadDepartment of Endocrinology, DMCH, Dhaka, Bangladesh.
Moosa MuradDepartment of Internal Medicine, Indira Gandhi Memorial Hospital, Malé, Maldives.
Soebagijo Adi SoelistijoDepartment of Endocrinology, Dr Soetomo General Academic Hospital Surabaya, Surabaya, Indonesia.
Johanes PurwotoDepartment of Endocrinology, MRCCC Siloam Hospitals, Jakarta, Indonesia.
Zanariah HusseinDepartment of Endocrinology, Putrajaya Hospital, Putrajaya, Malaysia.
Lee Chung HornDepartment of Diabetes and Endocrinology, Gleneagles Medical Centre, Singapore, Singapore.
Rakesh SahayDepartment of Endocrinology, Osmania Medical College, Hyderabad, India.
Noel SomasundaramDepartment of Endocrinology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Charles AntonypillaiDepartment of Endocrinology, Teaching Hospital, Kandy, Sri Lanka.
Manilka SumanathilakaDepartment of Endocrinology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Uditha BulugahapitiyaDepartment of Endocrinology, Colombo South Teaching Hospital, Kalubowila, Sri Lanka.
Bangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders · BDNational Hospital of Sri Lanka · LKApollo Gleneagles Hospitals · INApollo Hospitals · INBangalore Diabetes Centre · INBharti Hospital · INCARE Hospitals · INColombo North Teaching Hospital · LKDhaka Medical College and Hospital · BDFortis Hospital · INGleneagles Hospital · SGIndira Gandhi Memorial Hospital · MVKPC Medical College and Hospital · INMotilal Nehru Medical College · INOsmania Medical College · INPeerless Hospital & B.K.Roy Research Centre · INPondicherry Institute of Medical Sciences · INSiloam Eye Hospital · KRSt.John's Medical College Hospital · INTeaching Hospital Kandy · LK

Funding

Sanofi India -
6 · The paper itself

Abstract

aimTo develop an evidence-based expert group opinion on the role of insulin motivation to overcome insulin distress during different stages of insulin therapy and to propose a practitioner's toolkit for insulin motivation in the management of diabetes mellitus (DM).

backgroundInsulin distress, an emotional response of the patient to the suggested use of insulin, acts as a major barrier to insulin therapy in the management of DM. Addressing patient-, physician- and drug-related factors is important to overcome insulin distress. Strengthening of communication between physicians and patients with diabetes and enhancing the patients' coping skills are prerequisites to create a sense of comfort with the use of insulin. Insulin motivation is key to achieving targeted goals in diabetes care. A group of endocrinologists came together at an international meeting held in India to develop tool kits that would aid a practitioner in implementing insulin motivation strategies at different stages of the journey through insulin therapy, including pre-initiation, initiation, titration and intensification. During the meeting, emphasis was placed on the challenges and limitations faced by both physicians and patients with diabetes during each stage of the journey through insulinization. REVIEW

resultsAfter review of evidence and discussions, the expert group provided recommendations on strategies for improved insulin acceptance, empowering behavior change in patients with DM, approaches for motivating patients to initiate and maintain insulin therapy and best practices for insulin motivation at the pre-initiation, initiation, titration and intensification stages of insulin therapy.

conclusionsIn the management of DM, bringing in positive behavioral change by motivating the patient to improve treatment adherence helps overcome insulin distress and achieve treatment goals.

Indexed as

InitiationInsulin distressIntensificationMotivational interviewingPractitioner’s tool kitPre-initiationTitration

Identifiers

PMID31981212
PMCPMC7048897
OpenAlexW3001996553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.